These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10116495)

  • 1. Drug usage evaluation of warfarin sodium: the need for improved patient education.
    Hartwig SC
    Hosp Formul; 1992 Mar; 27(3):287-8, 300, 302. PubMed ID: 10116495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.
    Ellis RF; Stephens MA; Sharp GB
    Am J Hosp Pharm; 1992 Feb; 49(2):387-94. PubMed ID: 1554003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin: a quality assurance model for concurrent drug monitoring.
    Mattei TJ; Karnack CM; Rihn TL; Eder RA
    Hosp Pharm; 1985 Apr; 20(4):235-7, 240-1. PubMed ID: 10270729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
    Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
    Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a unit-of-use drug distribution system for the hospital emergency room.
    Schiavone JD
    Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automation in pharmacy: two institutions' experiences with novel distribution systems.
    Vrabel RB; Mackowiak L
    Hosp Formul; 1995 Feb; 30(2):106-13. PubMed ID: 10140349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug usage review in a community hospital.
    Kelly WN; White JA; Miller DE
    Am J Hosp Pharm; 1975 Oct; 32(10):1014-7. PubMed ID: 1190212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A medication use evaluation of alendronate: compliance with administration guidelines.
    Mersfelder T; Armitstead JA; Ivey MF; Cedars M
    Pharm Pract Manag Q; 1999 Jan; 18(4):50-8. PubMed ID: 10339068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacy Department standard procedures for clinical trial development].
    Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV
    Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdisciplinary inpatient warfarin education program.
    Scalley RD; Kearney E; Jakobs E
    Am J Hosp Pharm; 1979 Feb; 36(2):219-20. PubMed ID: 420211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical appropriateness, therapeutic equivalence, and cost of conversion of H2 antagonist therapy.
    Kitrenos JG; Brown DR; Letting DJ; Rotella DL
    Hosp Formul; 1993 Jan; 28(1):86-8, 91, 95-6. PubMed ID: 10123271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a drug usage evaluation program.
    Thornton J
    Hosp Formul; 1991 Dec; 26(12):971-2. PubMed ID: 10115411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of drug use in an intensive care hospital].
    Abel EH
    Infusionstherapie (1973); 1973 Dec; 1(2):162-4. PubMed ID: 4219016
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of criteria developed before formulary addition to evaluate misoprostol use.
    Rice KM; LeRoy ML; Ivey MF; Deck C; Krstenansky P
    Am J Hosp Pharm; 1992 Mar; 49(3):629-31. PubMed ID: 1598943
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluconazole dosing in renal impairment: a drug usage evaluation.
    Moody SB; Sveska KJ
    Hosp Formul; 1993 May; 28(5):499-502. PubMed ID: 10125807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to develop a successful DUE (drug usage evaluation) program: experience of a teaching medical center.
    Cheung MO
    Hosp Formul; 1994 Feb; 29(2):137-9, 142-3, 145. PubMed ID: 10131876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology.
    Bond CA; Raehl CL
    Pharmacotherapy; 2008 Jan; 28(1):1-13. PubMed ID: 18154468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.